Gregory Dussor Selected Research

Anisomycin

1/2021	De novo protein synthesis is necessary for priming in preclinical models of migraine.
4/2015	Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory Dussor Research Topics

Disease

35	Pain (Aches) 01/2022 - 11/2009
24	Migraine Disorders (Migraine) 01/2022 - 03/2010
23	Hypersensitivity (Allergy) 01/2022 - 08/2010
17	Hyperalgesia 07/2021 - 03/2010
12	Chronic Pain 01/2021 - 01/2012
9	Neuralgia (Stump Neuralgia) 01/2020 - 09/2011
8	Headache (Headaches) 02/2016 - 08/2010
5	Postoperative Pain 10/2019 - 01/2016
4	Inflammation (Inflammations) 06/2022 - 01/2020
4	Neoplasms (Cancer) 01/2021 - 07/2013
3	Asthma (Bronchial Asthma) 06/2022 - 01/2022
3	Respiratory Hypersensitivity 06/2022 - 01/2022
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 01/2016
3	Virus Diseases (Viral Diseases) 10/2020 - 01/2020
3	Peripheral Nerve Injuries 01/2020 - 09/2011
3	Nervous System Diseases (Neurological Disorders) 07/2018 - 08/2010
2	COVID-19 10/2020 - 05/2020
2	Neurogenic Inflammation 10/2020 - 05/2020
2	Surgical Wound 10/2019 - 01/2012
2	Secondary Headache Disorders 08/2010 - 03/2010
1	Hyperplasia 01/2022
1	Colitis 01/2021
1	Rheumatoid Arthritis 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Lung Diseases (Lung Disease) 10/2020
1	Ganglion Cysts (Ganglion) 01/2020
1	Visceral Pain 01/2020

Drug/Important Bio-Agent (IBA)

10	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2012
10	Pharmaceutical PreparationsIBA 01/2020 - 03/2010
9	Phosphotransferases (Kinase)IBA 01/2020 - 01/2012
8	Metformin (Glucophage)FDA LinkGeneric 10/2019 - 09/2011
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2011
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 05/2015
6	Calcitonin Gene-Related PeptideIBA 01/2022 - 12/2013
6	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2018
5	Eukaryotic Initiation Factor-4EIBA 01/2021 - 01/2017
5	AMP-Activated Protein KinasesIBA 10/2019 - 09/2011
5	Adenosine Monophosphate (AMP)IBA 07/2016 - 09/2011
5	Protein Kinases (Protein Kinase)IBA 07/2016 - 09/2011
4	RNA Cap-Binding Proteins (Cap Binding Protein)IBA 01/2021 - 01/2017
4	Sumatriptan (Imigran)FDA LinkGeneric 11/2020 - 08/2010
4	Mitogen-Activated Protein KinasesIBA 01/2020 - 07/2016
4	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2012
4	Analgesics (Analgesic Drugs)IBA 01/2018 - 11/2009
3	Peptide Hydrolases (Proteases)FDA Link 06/2022 - 01/2022
3	ProlactinIBA 01/2022 - 10/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
3	Protein Synthesis InhibitorsIBA 01/2021 - 07/2014
3	LigandsIBA 01/2021 - 05/2020
3	PAR-2 ReceptorIBA 01/2020 - 05/2015
3	tomivosertibIBA 01/2020 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 10/2019 - 07/2013
3	SolutionsIBA 01/2019 - 12/2011
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 07/2013
3	CarrageenanIBA 10/2018 - 04/2015
3	Acid Sensing Ion ChannelsIBA 01/2018 - 01/2011
2	AllergensIBA 06/2022 - 01/2022
2	Peptides (Polypeptides)IBA 01/2021 - 02/2010
2	AnisomycinIBA 01/2021 - 04/2015
2	Nitric Oxide DonorsIBA 11/2020 - 03/2010
2	Proteinase-Activated ReceptorsIBA 01/2020 - 05/2015
2	Estrogens (Estrogen)FDA Link 01/2020 - 12/2017
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020 - 10/2019
2	narciclasineIBA 10/2019 - 08/2019
2	MK-8722IBA 10/2019 - 08/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2019 - 01/2019
2	Opioid Analgesics (Opioids)IBA 02/2019 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 07/2013
2	Dopamine (Intropin)FDA LinkGeneric 10/2018 - 04/2015
2	Ion Channels (Ion Channel)IBA 01/2018 - 04/2014
2	ResveratrolIBA 01/2017 - 01/2012
2	Nerve Growth Factor (NGF)IBA 01/2017 - 07/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 01/2012
2	Conditioned Culture MediaIBA 10/2015 - 07/2014
2	Eukaryotic Initiation Factor-4F (EIF4F)IBA 05/2015 - 09/2011
2	U 0126 (UO 126)IBA 05/2015 - 01/2012
2	Irritants (Vesicants)IBA 01/2015 - 09/2012
2	Biological ProductsIBA 04/2014 - 08/2010
2	Tryptamines (Triptans)IBA 08/2010 - 03/2010
1	ArrestinIBA 06/2022
1	CLP257IBA 01/2022
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022
1	AntibodiesIBA 01/2022
1	olcegepantIBA 01/2022
1	TrypsinIBA 01/2022
1	PeptidomimeticsIBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021
1	calcitonin gene-related peptide (8-37)IBA 01/2021
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2020
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	1,2-dihydroxy-4-(nitroethenyl)benzene (SL-1)IBA 01/2020
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2020
1	LipidsIBA 01/2020
1	Testosterone (Sustanon)FDA Link 01/2020
1	InterferonsIBA 01/2020

Therapy/Procedure

19	Therapeutics 06/2022 - 02/2010
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
1	Injections 07/2021